Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06728241Recruiting
Virtual reality and AI therapy for psychosis
This study tests if virtual reality and artificial intelligence can help people with psychosis overcome difficulties going outside or doing everyday activities. It uses VR scenarios and AI tools to support treatment.
Oslo, NorwayAges 17–65 - NCT06728852RecruitingPhase 2
Vorolanib for advanced lung cancer after other treatments
This trial tests a targeted therapy pill called Vorolanib for people with advanced non-small cell lung cancer who have already tried at least two other treatments. It aims to see if the drug can help shrink or control the cancer.
Guangzhou, GuangdongAges 18–70 - NCT06728891Recruiting
Analyzing tumor deposits after stomach cancer surgery
This study looks at cancer cell deposits found in the area where the right and left stomach-supporting tissues meet, after surgery for stomach cancer. It may help doctors understand how cancer spreads and improve future treatment.
Hangzhou, ZhejiangAges 18–85 - NCT06729021Recruiting
Predicting leg blood clots after heart or lung surgery
This study tests whether a simple score (Modified Caprini) and a blood test (D-dimer) can help predict and prevent blood clots in the legs after heart or lung surgery. If you are having cardiothoracic surgery and will be in the hospital for a few days, you may be able to join.
BaghdadAges 18 years+ - NCT06729151Recruiting
Botox vs. standard care for bladder pain and sexual health
This study compares the effect of Botox injections into the bladder versus standard care (without injections) on sexual function in women with bladder pain syndrome. It aims to see if Botox can improve both pain and sexual health.
Bethesda, MarylandAges 18–99 - NCT06729203Recruiting
Ultrasound for belly fat and insulin resistance in women
This trial tests if ultrasound cavitation—a non-invasive treatment that uses sound waves to break down fat—can help lower insulin resistance in women with central obesity (fat around the belly). It's a possible option if you have insulin resistance and are not taking diabetes medication.
Giza, Giza GovernorateAges 25–40 - NCT06729814Recruiting
Repeated Breast Radiation Side Effects Study
This study asks whether having radiation therapy again to the same breast or chest (15 sessions over 3 weeks) causes more skin redness, peeling, or pain. The goal is to learn more about side effects so doctors can better prepare and support patients who need a second course of breast radiation.
Toronto, OntarioAges 18 years+ - NCT06730009RecruitingPhase 1/Phase 2
NK cell therapy after surgery for pancreatic or bile duct cancer
This trial tests whether adding natural killer (NK) cell therapy to standard chemotherapy after surgery can help prevent pancreatic or bile duct cancer from coming back. It is for patients who have had their tumor completely removed and are now ready for adjuvant chemotherapy.
TainanAges 18 years+ - NCT06730074Recruiting
Robotic exercise for Parkinson's motor and thinking skills
This study tests a new robotic system that combines movement and mental exercises for people with Parkinson's. It may help improve both your physical and thinking skills.
Ofakim, SouthAges 50–75 - NCT06730126RecruitingPhase 2
Soquelitinib for ALPS-FAS-related swelling and low blood counts
This trial tests an investigational drug called soquelitinib to see if it can shrink enlarged lymph nodes and improve low blood cell counts in people with ALPS-FAS. It may offer a new treatment option for those who have active symptoms.
Bethesda, MarylandAges 16–120 - NCT06730204Recruiting
Nutritional support for children with solid tumors
This trial studies whether a standardized nutrition plan helps children with newly diagnosed solid tumors. It aims to improve treatment outcomes through better nutrition.
Shanghai, Shanghai MunicipalityAges Up to 18 years - NCT06730607Recruiting
Predicting heart rhythm problems after myocarditis
This study uses heart MRI scans to predict who might develop dangerous heart rhythms after recovering from myocarditis. It aims to find better ways to monitor patients and prevent emergencies.
Rozzano, MilanAges 18 years+ - NCT06731218RecruitingPhase 1
A study on RGB-5088 for type 1 diabetes
This trial tests a new treatment called RGB-5088 in people with type 1 diabetes. It aims to see if the treatment is safe and if it helps control blood sugar.
Tianjin, Tianjin MunicipalityAges 18–60 - NCT06731270RecruitingPhase 2
Diclofenac for advanced lung cancer on immunotherapy
This trial tests whether adding the anti-inflammatory drug diclofenac can help people with advanced non-small cell lung cancer whose tumors are growing while on a single immunotherapy drug. You must have been on immunotherapy for at least 12 weeks and have a growing tumor, but your doctor does not plan to change your treatment right away.
Atlanta, GeorgiaAges 18 years+ - NCT06731361Recruiting
Better prescribing for older nursing home residents
This study tests a better way for doctors to prescribe medicines for older nursing home residents. The goal is to make sure prescriptions are safer and more tailored to each person.
Apeldoorn, GelderlandAges 65 years+ - NCT06731530Recruiting
Eye structure and strength in pseudoexfoliation
This study looks at how the clear front part of the eye, called the cornea, changes in people with a condition called pseudoexfoliation. It may help doctors understand how this condition affects eye strength and vision after cataract surgery.
ThessalonikiAges 60–80 - NCT06731673Recruiting
HSP47 protein study in blood clots
This study looks at a protein called HSP47 in people with blood clots, heart attacks, or strokes caused by atrial fibrillation, compared to healthy volunteers. It aims to learn more about how blood clots form and may lead to better treatments.
Aarhus, Central RegionAges 18 years+ - NCT06731868RecruitingPhase 1/Phase 2
Study of an experimental tablet for tardive dyskinesia
This study tests an experimental once-daily tablet for moderate-to-severe tardive dyskinesia, a condition causing uncontrollable repetitive movements. It aims to see if the drug is safe and reduces these symptoms over time.
ShanghaiAges 18–64 - NCT06732492RecruitingPhase 1
RD13-02 cell therapy for relapsed CD7+ NK/T lymphoma
This trial uses a new type of immune cell (RD13-02) to treat a rare and aggressive lymphoma that hasn't responded to other treatments. It targets cancer cells that carry a specific marker called CD7.
Wuhan, HubeiAges 3–70 - NCT06732505RecruitingPhase 1
Ac-225 DOTATATE for SSTR+ GEP-NETs: A Safety Study
This trial tests a new drug, Ac-225 DOTATATE, in people with a type of gut or pancreas tumor (GEP-NET) that has specific proteins (SSTR) on its surface. The goal is to see if it is safe and helps shrink or slow the tumor.
Beijing, Beijing MunicipalityAges 18–80 - NCT06732791Recruiting
Comparing two trauma scores for multiple injury patients
This study compares two simple scoring tools (MGAP and GAP) to see which better predicts outcomes in people with injuries to more than one body area. If you or a loved one has multiple traumatic injuries and arrives at the ER within 6 hours, this trial may help improve how doctors assess care.
BaghdadAges 16 years+ - NCT06732856RecruitingPhase 1/Phase 2
Zolbetuximab plus chemo before stomach cancer surgery
This trial tests a new drug called zolbetuximab combined with chemotherapy (docetaxel, oxaliplatin, S-1) before surgery for people with locally advanced stomach cancer that has a specific protein (CLDN18.2). The goal is to see if this combination shrinks tumors enough to improve surgery outcomes.
SeoulAges 19 years+ - NCT06732869Recruiting
Phone coaching for physical activity in COPD rehab
This study tests a coaching program delivered through your smartphone to help people with COPD stay active while in pulmonary rehab. It aims to improve how much daily activity you can do and how you feel.
LeiriaAges 40 years+ - NCT06733038RecruitingPhase 3
Chemo plus Avastin with or without Tecentriq for advanced colorectal cancer
This trial tests whether adding the immunotherapy drug atezolizumab (Tecentriq) to standard chemotherapy (FOLFOXIRI) and bevacizumab (Avastin) is more effective as a first treatment for people with a specific type of metastatic colorectal cancer that has a high immune score and is mismatch repair proficient.
Brescia, BSAges 18–75
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.